New Antifungal Drugs, New Approaches and Vaccines

New and emerging treatments for fungal infections.

20 October 2017

Biafungin (CD101), a Novel Echinocandin, Displays a Long Half-life in the Chimpanzee, Suggesting a Once-Weekly IV Dosing Option

20 October 2017

Biafungin (CD101), a Novel Echinocandin, Displays an Uncommonly Long Half-life in Multiple Species

20 October 2017

C101 (biafungin) entry on BIOCENTURY

20 October 2017

Novel Macrocyclic Amidinoureas: Potent Non-Azole Antifungals Active against Wild-Type and Resistant Candida Species

In vitro

23 July 2013

Latest information on SCY-078 (MK-3118; enfumafungin) from Scynexis

20 October 2017

Enfumafungin derivative MK-3118 shows increased in vitro potency against clinical echinocandin-resistant Candida Species and Aspergillus species isolates.

In vitro

16 January 2014

Clone of Antifungal activities of SCY-078 (MK-3118) and standard antifungal agents against clinical non-Aspergillus mold isolates.

14 July 2015

Discovery of Plant Sterol-Derived Gamma-Secretase Modulators by Molecular Editing of a Triterpenoid Glycoside

27 October 2013

Design, synthesis, and docking of highly hypolipidemic agents: Schizosaccharomyces pombe as a new model for evaluating alpha-asarone-based HMG-CoA reductase inhibitors.

15 June 2010